tetano
Editor, Senior Moderator
Diagn Microbiol Infect Dis. 2018 Nov 23. pii: S0732-8893(18)30663-1. doi: 10.1016/j.diagmicrobio.2018.11.013. [Epub ahead of print]
[h=1]Near point-of-care adoption of Cepheid Xpert? Flu/RSV XC testing within an integrated healthcare delivery network.[/h] Hernandez DR[SUP]1[/SUP], Pellitteri GP[SUP]2[/SUP], Kimmich DJ[SUP]3[/SUP], Heiter BJ[SUP]4[/SUP], Smeal K[SUP]5[/SUP], Wolk DM[SUP]6[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Flu/RSV testing was implemented in out-patient clinic-based physician office laboratories throughout Pennsylvania. On-site testing reduced the collect-to-result time by 70% when compared to testing in a centralized core laboratory; over- or under-treatment for influenza A and B (measured by anti-viral prescription) was reduced by 15% (P < 0.0001). Antimicrobial prescription was not affected by on-site testing.
[h=4]KEYWORDS:[/h] Flu; Flu test; Point-of-care; RSV
PMID: 30581009 DOI: 10.1016/j.diagmicrobio.2018.11.013
[h=1]Near point-of-care adoption of Cepheid Xpert? Flu/RSV XC testing within an integrated healthcare delivery network.[/h] Hernandez DR[SUP]1[/SUP], Pellitteri GP[SUP]2[/SUP], Kimmich DJ[SUP]3[/SUP], Heiter BJ[SUP]4[/SUP], Smeal K[SUP]5[/SUP], Wolk DM[SUP]6[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Flu/RSV testing was implemented in out-patient clinic-based physician office laboratories throughout Pennsylvania. On-site testing reduced the collect-to-result time by 70% when compared to testing in a centralized core laboratory; over- or under-treatment for influenza A and B (measured by anti-viral prescription) was reduced by 15% (P < 0.0001). Antimicrobial prescription was not affected by on-site testing.
[h=4]KEYWORDS:[/h] Flu; Flu test; Point-of-care; RSV
PMID: 30581009 DOI: 10.1016/j.diagmicrobio.2018.11.013